Amgen AMGN
NASDAQ AMGN
$437.23 -6.89 (-1.55%)
At close: Sep 4, 2026 · 4:00 PM EDT

Amgen (AMGN) EV to FCF (2009 - 2026)

Amgen (AMGN) posted EV to FCF of 52.1 for Q2 2026, down 56.73% on a QoQ basis from 120.42 in Q1 2026, and down 30.02% year-over-year from 74.45 in Q2 2025.

Analysis

Amgen (AMGN) EV to FCF (2009 - 2026) Analysis & Trends

Amgen has reported EV to FCF for 18 years, with the latest figure at 52.1 in Q2 2026.

  • On a quarterly basis, EV to FCF fell 30.02% year-over-year to 52.1 in Q2 2026; TTM through Jun 2026 was 17.86, a 33.17% increase from a year earlier, with the FY2025 full-year figure at 20.65, up 67.69% from the prior year.
  • EV to FCF was 52.1 for Q2 2026 at Amgen, down from 120.42 in the prior quarter.
  • The five-year high for EV to FCF was 495.72 in Q4 2023, with the low at 22.02 in Q2 2023.
  • Average EV to FCF over 5 years is 111.37, with a median of 66.76 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: EV to FCF surged 774.12% in 2023, then tumbled 94.13% in 2024.
  • Over 5 years, EV to FCF stood at 56.71 in 2022, then soared by 774.12% to 495.72 in 2023, then sank by 94.13% to 29.08 in 2024, then soared by 498.33% to 174.01 in 2025, then plunged by 70.06% to 52.1 in 2026.
  • The last three EV to FCF figures came in at 52.1 (Q2 2026), 120.42 (Q1 2026), and 174.01 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.10
Mar 31, 2026 120.42
Dec 31, 2025 174.01
Sep 30, 2025 33.55
Jun 30, 2025 74.45
Mar 31, 2025 161.95
Dec 31, 2024 29.08
Sep 30, 2024 49.54
Jun 30, 2024 71.39
Mar 31, 2024 311.11
Dec 31, 2023 495.72
Sep 30, 2023 43.42
Jun 30, 2023 22.02
Mar 31, 2023 135.51
Dec 31, 2022 56.71
Sep 30, 2022 38.60
Jun 30, 2022 73.02
Mar 31, 2022 62.13
Dec 31, 2021 46.63
Sep 30, 2021 49.28